Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA082923-02
Application #
6174068
Study Section
Special Emphasis Panel (ZCA1-SRRB-7 (M1))
Program Officer
Menkens, Anne E
Project Start
1999-09-01
Project End
2003-06-30
Budget Start
2000-07-01
Budget End
2001-06-30
Support Year
2
Fiscal Year
2000
Total Cost
$236,218
Indirect Cost

  Institution

Name
University of California San Francisco
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143

  Publications

Sennino, Barbara; Ishiguro-Oonuma, Toshina; Schriver, Brian J et al. (2013) Inhibition of c-Met reduces lymphatic metastasis in RIP-Tag2 transgenic mice. Cancer Res 73:3692-703
Cyran, Clemens C; Fu, Yanjun; Rogut, Victor et al. (2013) Evaluation of a novel macromolecular cascade-polymer contrast medium for dynamic contrast-enhanced MRI monitoring of antiangiogenic bevacizumab therapy in a human melanoma model. Acad Radiol 20:1256-63
Baluk, Peter; Hogmalm, Anna; Bry, Maija et al. (2013) Transgenic overexpression of interleukin-1? induces persistent lymphangiogenesis but not angiogenesis in mouse airways. Am J Pathol 182:1434-47
Cyran, Clemens C; Sennino, Barbara; Fu, Yanjun et al. (2012) Permeability to macromolecular contrast media quantified by dynamic MRI correlates with tumor tissue assays of vascular endothelial growth factor (VEGF). Eur J Radiol 81:891-6
Banfi, Andrea; von Degenfeld, Georges; Gianni-Barrera, Roberto et al. (2012) Therapeutic angiogenesis due to balanced single-vector delivery of VEGF and PDGF-BB. FASEB J 26:2486-97
Sennino, Barbara; Ishiguro-Oonuma, Toshina; Wei, Ying et al. (2012) Suppression of tumor invasion and metastasis by concurrent inhibition of c-Met and VEGF signaling in pancreatic neuroendocrine tumors. Cancer Discov 2:270-87
Falcon, Beverly L; Pietras, Kristian; Chou, Jeyling et al. (2011) Increased vascular delivery and efficacy of chemotherapy after inhibition of platelet-derived growth factor-B. Am J Pathol 178:2920-30
Falcon, Beverly L; Barr, Sharon; Gokhale, Prafulla C et al. (2011) Reduced VEGF production, angiogenesis, and vascular regrowth contribute to the antitumor properties of dual mTORC1/mTORC2 inhibitors. Cancer Res 71:1573-83
Witte, Marlys H; Dellinger, Michael T; McDonald, Donald M et al. (2011) Lymphangiogenesis and hemangiogenesis: potential targets for therapy. J Surg Oncol 103:489-500
You, Weon-Kyoo; Sennino, Barbara; Williamson, Casey W et al. (2011) VEGF and c-Met blockade amplify angiogenesis inhibition in pancreatic islet cancer. Cancer Res 71:4758-68

Showing the most recent 10 out of 66 publications